Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Blyth

Showing results (291-300 of 298) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 298 results.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Comparative B cell and antibody responses induced by adenoviral vectored and mRNA vaccines against COVID-19Yi Liu, Stephany Sánchez-Ovando, Louise Carolan, et al.
Vaccine|October 30, 2023
Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccinesYi Liu, Stephany Sánchez-Ovando, Louise Carolan, et al.
The Medical Journal of Australia|February 24, 2022
COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statementEliska Furlong, Rishi S Kotecha, Rachel Conyers, et al.
The Lancet. Global Health|January 31, 2025
Effectiveness of 2023 southern hemisphere influenza vaccines against severe influenza-associated illness: pooled estimates from eight countries using the test-negative designRadhika Gharpure, Annette K Regan, Francisco Nogareda, et al.
Nature Immunology|November 4, 2024
Novel coenzyme Q6 genetic variant increases susceptibility to pneumococcal diseaseEmma C Walker, Sarah Javati, Elizabeth M Todd, et al.
Vaccine|May 17, 2026
SARS-CoV-2 Ancestral and Omicron variant immunity in Australian children in 2023, a seroprevalence studyArchana Koirala, Shayal A Prasad, M Christian Tjiam, et al.
MMWR. Morbidity and Mortality Weekly Report|September 25, 2025
Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness - Eight Southern Hemisphere Countries, March-September 2025Savanah Russ, Francisco Nogareda, Annette K Regan, et al.
Plos One|September 18, 2024
The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: A cross-sectional studyArchana Koirala, Jocelynne McRae, Philip N Britton, et al.
Pageof 30

Showing results (291-300 of 298) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 298 results.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Comparative B cell and antibody responses induced by adenoviral vectored and mRNA vaccines against COVID-19Yi Liu, Stephany Sánchez-Ovando, Louise Carolan, et al.
Vaccine|October 30, 2023
Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccinesYi Liu, Stephany Sánchez-Ovando, Louise Carolan, et al.
The Medical Journal of Australia|February 24, 2022
COVID-19 vaccination in children and adolescents aged 5 years and older undergoing treatment for cancer and non-malignant haematological conditions: Australian and New Zealand Children's Haematology/Oncology Group consensus statementEliska Furlong, Rishi S Kotecha, Rachel Conyers, et al.
The Lancet. Global Health|January 31, 2025
Effectiveness of 2023 southern hemisphere influenza vaccines against severe influenza-associated illness: pooled estimates from eight countries using the test-negative designRadhika Gharpure, Annette K Regan, Francisco Nogareda, et al.
Nature Immunology|November 4, 2024
Novel coenzyme Q6 genetic variant increases susceptibility to pneumococcal diseaseEmma C Walker, Sarah Javati, Elizabeth M Todd, et al.
Vaccine|May 17, 2026
SARS-CoV-2 Ancestral and Omicron variant immunity in Australian children in 2023, a seroprevalence studyArchana Koirala, Shayal A Prasad, M Christian Tjiam, et al.
MMWR. Morbidity and Mortality Weekly Report|September 25, 2025
Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness - Eight Southern Hemisphere Countries, March-September 2025Savanah Russ, Francisco Nogareda, Annette K Regan, et al.
Plos One|September 18, 2024
The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: A cross-sectional studyArchana Koirala, Jocelynne McRae, Philip N Britton, et al.
Pageof 30